Category Archives: Interventional Cardiology

This transcript has been edited for clarity. Hi. This is Dr Michelle O'Donoghue, reporting for Medscape. Continue reading →

The single-use medical device reprocessing market was valued at USD 1,858.2 million in 2018 and is expected to register a CAGR of about 15.24% during the forecast period, 2019-2024. Reprocessing of single-use devices (SUDs) helps in saving costs and reducing medical waste. Reuse of single-use devices involves regulatory, ethical, medical, legal, and economic issues and has been extremely controversial for more than two decades Continue reading →

Selbyville, Delaware, this detailed presentation on Contrast Media Injectors market available at MarketStudyReport.com, features an exhaustive study conveying influential trends prevailing in the global business sphere. The report also presents significant details concerning market size, market share and profit estimations to offer an ensemble prediction about this business. Continue reading →

Market Growth Insight has presented an updated research report on the Global Interventional Cardiology and Peripheral Vascular Device market which offers insights on key aspects and overview of the fundamental verticals of the market. The Interventional Cardiology and Peripheral Vascular Device report aims to assist business owners, distributors, suppliers, and stakeholders with insights on key facts and figures. Global Interventional Cardiology and Peripheral Vascular Device study provides effective strategies for the forecast period 2020-2026 that comprise marker share, market size, growth rate, and influential factors Continue reading →

(UPDATED) The European Society of Cardiology and European Association for Cardio-Thoracic Surgery (ESC/EACTS) have agreed to review the latest evidence supporting their current revascularization recommendations for patients with left main coronary artery disease. The decision adds yet another wrinkle to a yearlong and frequently hostile dispute between the surgical and interventional cardiology communities over the EXCEL trial, a study of PCI versus CABG for patients with left main CAD. That trial has come under repeated fire since one of the studys surgeons broke with the research team following a disagreement over the study findings Continue reading →

Photo by Scott Lowe | Dr. Schultz Continue reading →

Doctors say around 1-2% of covid-recovered patients are coming back to them with inflammation of heart; some as young as six yrs of age Doctors were concerned when a six-year-old boy, who had recovered from covid-19 recently, come back to them with heart complications. Continue reading →

Persistence Market Research recently published a market study that sheds light on the growth prospects of the global Pediatric Interventional Cardiology Devices market during the forecast period (20XX-20XX). In addition, the report also includes a detailed analysis of the impact of the novel COVID-19 pandemic on the future prospects of the Pediatric Interventional Cardiology Devices market. The report provides a thorough evaluation of the latest trends, market drivers, opportunities, and challenges within the global Pediatric Interventional Cardiology Devices market to assist our clients arrive at beneficial business decisions. Continue reading →

A speedy trip to the cath lab for coronary angiography is not linked to better outcomes in patients who suffer an out-of-hospital cardiac arrest but do not have ST-segment elevation on an initial ECG, a meta-analysis shows. In pooled results from 11 studies, there were no differences in 30-day mortality, the likelihood of good neurological status, or the rate of PCI based on whether patients underwent early or nonearly angiography, according to the analysis published in the October 12, 2020, issue of JACC: Cardiovascular Interventions. Continue reading →

The CIMS Cardiology Conference & Awards held on World Heart Day September 29 to felicitate the achievers in the healthcare industry witnessed virtual participation from all India under various domains in cardiology specialty such as hospital units, healthcare practitioners, pharma companies, medical companies, hospitals and research institutions. Continue reading →